Resveratrol ameliorates early diabetic nephropathy associated with suppression of augmented TGF-β/smad and ERK1/2 signaling in streptozotocin-induced diabetic rats
- PMID: 21300041
- DOI: 10.1016/j.cbi.2011.01.033
Resveratrol ameliorates early diabetic nephropathy associated with suppression of augmented TGF-β/smad and ERK1/2 signaling in streptozotocin-induced diabetic rats
Abstract
Diabetic nephropathy (DN) is the major cause of end-stage renal disease. The early changes in DN are characterized by an increased in kidney size, glomerular volume, and kidney function, followed by the accumulation of glomerular extracellular matrix, increased urinary albumin excretion (UAE), glomerular sclerosis, and tubular fibrosis. Resveratrol (RSV) has been shown to ameliorate hyperglycemia and hyperlipidemia in streptozotocin-induced diabetic rats. In the present study, we examined the beneficial effects of RSV on DN and explored the possible mechanism of RSV action. Male Sprague-Dawley rats were injected with streptozotocin at 65mg/kg body weight. The induction of diabetes mellitus (DM) was confirmed by a fasting plasma glucose level ≥300mg/dL and symptoms of polyphagia and polydipsia. The DM rats were treated with or without RSV at 0.75mg/kg body weight 3 times a day for 8 weeks. Animals were sacrificed and kidney histology was examined by microscopy. Urinary albumin excretion, glomerular hypertrophy and expressions of fibronectin, collagen IV, and TGF-β in the glomeruli were alleviated in RSV-treated DM rats, but not in untreated DM rats. In addition, RSV treatment reduced the thickness of the glomerular basement membrane (GBM) to the original thickness and increased nephrin expressions to normal levels in DM rats. Moreover, RSV inhibited phosphorylation of smad2, smad3 and ERK1/2 in diabetic rat kidneys. This is the first report showing that RSV alleviates early glomerulosclerosis in DN through TGF-β/smad and ERK1/2 inhibition. In addition, podocyte injuries of diabetic kidneys are lessened by RSV.
2011 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Resveratrol ameliorates vasculopathy in STZ-induced diabetic rats: role of AGE-RAGE signalling.Diabetes Metab Res Rev. 2010 Mar;26(3):212-22. doi: 10.1002/dmrr.1076. Diabetes Metab Res Rev. 2010. PMID: 20474069
-
Preventive effects of rutin on the development of experimental diabetic nephropathy in rats.Life Sci. 2012 Nov 2;91(19-20):959-67. doi: 10.1016/j.lfs.2012.09.003. Epub 2012 Sep 20. Life Sci. 2012. PMID: 23000098
-
Extracellular superoxide dismutase ameliorates streptozotocin-induced rat diabetic nephropathy via inhibiting the ROS/ERK1/2 signaling.Life Sci. 2015 Aug 15;135:77-86. doi: 10.1016/j.lfs.2015.04.018. Epub 2015 May 23. Life Sci. 2015. PMID: 26006040
-
Diabetic nephropathy and transforming growth factor-beta: transforming our view of glomerulosclerosis and fibrosis build-up.Semin Nephrol. 2003 Nov;23(6):532-43. doi: 10.1053/s0270-9295(03)00132-3. Semin Nephrol. 2003. PMID: 14631561 Review.
-
The key role of the transforming growth factor-beta system in the pathogenesis of diabetic nephropathy.Ren Fail. 2001 May-Jul;23(3-4):471-81. doi: 10.1081/jdi-100104730. Ren Fail. 2001. PMID: 11499562 Review.
Cited by
-
Resveratrol Modulates Transforming Growth Factor-Beta (TGF-β) Signaling Pathway for Disease Therapy: A New Insight into Its Pharmacological Activities.Biomedicines. 2020 Jul 31;8(8):261. doi: 10.3390/biomedicines8080261. Biomedicines. 2020. PMID: 32752069 Free PMC article. Review.
-
Antifibrotic effects of KS370G, a caffeamide derivative, in renal ischemia-reperfusion injured mice and renal tubular epithelial cells.Sci Rep. 2014 Jul 24;4:5814. doi: 10.1038/srep05814. Sci Rep. 2014. PMID: 25056456 Free PMC article.
-
Protective effect of resveratrol against aluminum chloride induced nephrotoxicity in rats.Saudi Med J. 2016 Apr;37(4):369-78. doi: 10.15537/smj.2016.4.13611. Saudi Med J. 2016. PMID: 27052279 Free PMC article.
-
Resveratrol delays the progression of diabetic nephropathy through multiple pathways: A dose-response meta-analysis based on animal models.J Diabetes. 2024 Sep;16(9):e13608. doi: 10.1111/1753-0407.13608. J Diabetes. 2024. PMID: 39264004 Free PMC article.
-
Resveratrol inhibits the epithelial sodium channel via phopshoinositides and AMP-activated protein kinase in kidney collecting duct cells.PLoS One. 2013 Oct 24;8(10):e78019. doi: 10.1371/journal.pone.0078019. eCollection 2013. PLoS One. 2013. PMID: 24205069 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous